Stephen J. Moore

Senior Director
Vega Therapeutics
South San Francisco, California, United States

Presentation(s):

• PB1311 - Prophylactic Efficacy Of VGA039, An Anti-Protein S Monoclonal Antibody, In A Novel Non-Human Primate Model Of Acquired Von Willebrand Disease

  Tuesday, June 27, 2023
  18:30 – 19:30 ET